system. In IMR-32 neuroblastoma cells, Zn deficiency leads not only to protein thioloxidation but to a decrease in GSH levels, which is prevented by Zn supplementation (Mackenzie et al. 2006b ).
GSHis central in the metabolism of H 2 O 2 and lipid peroxides, can react with carbon centered radicals, and participates in the detoxification of xenobiotics through conjugation reactions (Forman et al. 2009 ). Furthermore, through its key role in the maintenance of an optimal intracellular redox environment, GSH is part of numerous basic cellular processes including the regulation of redox signaling, protein and DNA synthesis, DNA repair, cell proliferation, and programmed cell death (Circu and Aw 2010; Jones 2008) . GSH is absolutely essential for mammalian life as evidenced by the embryonic lethality observed in glutamate cysteine ligase (GCL) knockout mice (Dalton et al. 2000) . The synthesis of GSH, a tripeptide (γ-glutamylcysteinylglycine), from its constituent aminoacids is both constitutive and regulated. GSH is synthesized through the concerted action of two enzymes, GCL and glutathione synthase. GCL catalyzes the formation of γ-glutamylcysteine, the rate-limiting step for de novo GSH synthesis. GCL consists of a catalytic subunit (GCLC, 73 kDa), which contributes to all the enzymatic activity containing the substrate binding sites. The GCL modifier subunit (GCLM, 31 kDa), modulates the affinity of GCLC for substrates and inhibitors. GCL belongs to the group of phase II detoxification enzymes and its expression is regulated by transcription factor nuclear factor (erythroid-derived 2)-like 2 (Nrf-2) (Hansen et al. 2004 ). The expression of both GCL subunits is induced in response to various agents, including oxidative stressors. The inducible nature of GCL makes it a crucial component of the cellular adaptation machinery for resistance against oxidative stress(Circu and Aw 2010; Forman et al. 2009 ).
Zn deficiency not only can cause oxidative stress but also increases the susceptibility of neurons to pro-oxidant stressors, including lead and iron(Aimo and Oteiza 2006; Mackenzie et al. 2002a) . Extensive evidence supports a role for dopamine (DA)-mediated oxidative stress in the neurotoxicity associated with the development of neurodegenerative processes (e.g. Parkinson´s disease (PD)). DA is a neurotransmitter that can undergo oxidation to form quinone and semiquinone derivatives that are highly reactive towards sulfhydryl groups. The thiol-containing compounds GSH, cysteine, and N-acetyl cysteine prevent DA autoxidation in vitro, and decrease the size of damaged area in rat striatum when co-injected with DA(Soto- Otero et al. 2000) . Survival of dopaminergic neurons crucially depends on a tight regulation of their GSH levels, being GSH synthesis upregulated upon DA exposure (Jia et al. 2008) . GSH deficits have been found in the brain of PD and schizophrenic patients which could constitute a causative insult triggering neuronal degeneration (Garrido et al. 2011; Gysin et al. 2007 ). On the other hand, the mobilization of Zn from metallothionein, as a consequence of DAmediated metallothioneinthiol oxidation, has been proposed as a protective neuronal response against DA-induced oxidative damage (Eibl et al. 2010) .Furthermore,Zn deficiency-induced epigenetic alterations in the metal responsive elements (MREs) within the promoter region of the metallothionein gene (Kurita et al. 2013 ) could be also involved in an increased susceptibility to oxidative stressors (e.g. DA).
We propose that Zn deficiency-induced neuronal oxidative stress and the increased susceptibility of Zn deficient neuronal cells to oxidative stressors could be in part due to an impaired GSH synthesis when neuronal Zn decreases. To test this hypothesis, the effects Zn deficiency on the regulation of GCL expression and GSH levels were investigated in fetal rat brain and in human IMR-32 neuroblastoma cells. The capacity of Zn deficient neuronal cells to up-regulate GCL in response to DA-mediated neuronal injury was also studied. (Keen et al. 1989 ). Animals were fed the control diet for one week before breeding. Males and females were caged together overnight and the following morning the presence of a sperm plug confirmed a successful breeding. On gestation day (GD) 0, rats (9 animals/group) were divided into two groups and fed ad libitum a control diet (25 µg Zn/g diet), or a diet containing a marginal concentration of Zn (10 µg Zn/g diet, MZ) until GD19. Food intake was recorded daily, and body weight was measured at 5-d intervals. Food intake and body weight gain throughout gestation were similar in both groups. At GD19, dams were anesthetized with isofluorane (2mg/kg body weight), and laparatomies were performed.
Materials and Methods

Materials
The gravid uterus was removed, and fetuses collected. Fetal brains were excised, rinsed in ice-cold PBS, the meninges removed, weighed and processed for GSH determination (3 brains per litter), Western blot and real-time polymerase chain reaction (RT-PCR) (1 brain/litter, respectively). This experimental model in rats is considered as a condition of marginal zinc nutrition because it affords normal pregnancy and fetal outcomes, while zinc deficiency causes profound effects on pregnancy outcomeand teratogenicity (Aimo et al. 2010b ). 1  2  3  4  5  6  7  8  9  10  11  12  13  14  15  16  17  18  19  20  21  22  23  24  25  26  27  28  29  30  31  32  33  34  35  36  37  38  39  40  41  42  43  44  45  46  47  48  49  50  51  52  53  54  55  56  57  58  59 60
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Cell cultures
Zn deficient fetal bovine serum (FBS) was prepared by chelation with diethylenetriaminepentaacetic acid as previously described (Duffy et IMR-32 cells were cultured at 37 ºC in complex medium supplemented with 10 % (v/v) FBS and antibiotics-antimicotic (50 units/ml penicillin, 50 µg/ml streptomycin, and 0.125 µg/ml amphotericin B).Cells were grown in complex medium containing 10% (v/v) non-chelated FBS until 90% confluence. IMR-32 cells were subsequently incubated in control non-chelated medium or in chelated media containing 1.5 µM Zn. In some experiments, 50 µM DA was added and cells were harvested after 6-24 h in culture. For GSH and GSSG determinations by HPLC, a 3-aminopropyl)column was used.
Themobile phase was formed by a gradient with two solvent systems (80 % (v/v) methanol/water and acetate buffered methanol, pH 4.6) that were mixed as described (Jones et al. 1998) . Fluorescent detection of GSH was done at λexc: 395 nm and λem: 510-650 nm. 
Western blot analysis
Determination of mRNA levels
Total RNA was extracted from fetal brain and cells using an optimized RNA extraction protocol based on the RNeasy Mini Kit Isolation System (Qiagen Ltd.) according to the manufacturer's protocol. Cells were grown in 6-well plates, and after the corresponding treatments resuspended in 350 µl of lysis buffer and homogenized using QIA shredder (Qiagen Ltd.) at 8,000 g for 2 min. The RNA was eluted using 50 µl of nuclease-free water and stored at −80°C until use. cDNA was synthesized using the SuperScript III First-Strand Synthesis System for RT-PCR (Invitrogen) according to the manufacturer's protocol. Samples were stored at −80 °C.
The expression of GCLC and GCLM mRNA was determined by RT-PCR using the following primers: for rat GCLC 5′-GGGAAGGAAGGCGTGTTTCCT-3′ (forward) and 5′-GTCGACTTCCATGTTTTCAAGGT-3′ (reverse); for rat GCLM 5′-CCAGGAGTG GGTGCCACTGT-3′ (forward) and 5′-TTTGACTTGATGATTCCTCTGCTT-3′
(reverse); for human GCLC 5′-GGCTGAGTGTCCGTCTCG-3′ (forward) and 5′-GTGGTAGATGTGCAGGAACT-3′ (reverse); for human GCLM 5′-GCCCTTTA AAGAGACGTGTAGGAA-3′ (forward) and 5′-CCGCCTGGTGAGGTAGAC-3′
(reverse). RT-PCR was conducted using iQiCycler Detection System (BioRad Laboratories, Ltd), and PCR amplification was then detected with the SYBR green fluorophore. A control cDNA dilution series was created for the gene to establish a standard curve. Each reaction was subjected to melting-point analysis to confirm single amplified products. The data generated from each PCR were analyzed using iQiCycler
Optical System Software Verson 3.0a (BioRad Laboratories, Ltd). The housekeeping gene RiboL32 was used as an endogenous control. The primers for the amplification of human RiboL32 were as follows: 5′-GAAACTCGCGGAAACCCA-3′ (forward) and 5′-
GGATCTGGCCCTTGAACCTTC-3′
(reverse); and for rat RiboL325′-
GAAACTCGCGGAAACCCA-3′ (forward) and 5′-AGATCTGGCCCTTGAATCTTC -3′ (reverse).
Assay of GCL activity
GCL activity was measured inIMR-32 cell soluble fractions using the 96-well microtiter min. The fluorescence ratio of γ-glutamylcysteine/GSH was measured at λex: 427 nm and λem: 528 nm.
Electrophoretic mobility shift assay (EMSA)
Nuclear fractions were isolated as previously described (Osborn et al. 1989) , with minor modifications (Mackenzie et al. 2002b) . Protein concentration was measured as described by Bradford (Bradford 1976 mMNaCl, and 0.25 mg/ml poly(dI-dC)]. The products were separated by electrophoresis in a 6% (w/v) non-denaturing polyacrilamide gel using 0.5 X TBE (Tris/borate 45 mM, EDTA 1mM) as the running buffer. The gels were dried and the radioactivity quantified in a Phosphoimager 840 (Amersham Pharmacia Biotech. Inc.,Piscataway, NJ).
Assay of caspase-3 activity
Caspase-3 activity was determined in cell lysates after incubating IMR-32 cells for 6 or 24 h, in control or chelated media containing 1.5 µM Zn in the absence or in the presence of DA (50µM). Caspase-3 activity was measured using the ApoAlert-Caspase-3 Assay following the manufacturer's protocol. 1  2  3  4  5  6  7  8  9  10  11  12  13  14  15  16  17  18  19  20  21  22  23  24  25  26  27  28  29  30  31  32  33  34  35  36  37  38  39  40  41  42  43  44  45  46  47  48  49  50  51  52  53  54  55  56  57  58  59 60
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Statistical analysis
One way analysis of variance (ANOVA) with subsequent post hoc comparisons by Scheffe, were performed using Statview 5.0.1 (Brainpower Inc., Calabazas CA). A p value < 0.05 was considered statistically significant. Values are given as means ± SEM.
Results
Zn deficiency diminishes GSH, GCL protein and mRNA levels in rat fetal brain
We previously observed that feeding rats marginal Zn (MZ) diets throughout gestation causes a decrease in zinc concentration and increased tubulin thiol oxidation in the brain of GD19 fetuses [8] . We now investigated in the same experimental model, if gestational MZ nutrition could affect GD19 fetal brain GSH and GCL levels. In MZ fetal brains, GSH content was significantly lower (21%) compared to controls ( Figure 1A ).To evaluate if the decrease in GSH content could be associated with an impaired GSH de novo synthesis, the expression of GCL subunits was assessed measuring protein levels by immunoblotting, and mRNA levels by RT-PCR. GD19 fetal brain GCLC and GCLM protein levels were 25 and 40 % lower, respectively, in the MZ group compared to controls ( Figure 1B) . Accordingly, the mRNA levels of Gclc and Gclm subunits were 29 and 44% lower in MZ fetal brains than in controls (Figure 1 C) . 1  2  3  4  5  6  7  8  9  10  11  12  13  14  15  16  17  18  19  20  21  22  23  24  25  26  27  28  29  30  31  32  33  34  35  36  37  38  39  40  41  42  43  44  45  46  47  48  49  50  51  52  53  54  55  56  57  58  59  60 binding was 35% lower in nuclear fractions isolated from MZ rat fetal brains compared to controls (Figure 3 ). Nrf2-DNA binding in nuclear fractions isolated from IMR-32 cells incubated for 24 h in Zn deficient medium was 30% lower than in controls (Figure 3) . Accordingly, Nrf2 protein levels in nuclear fractions from the Zn deficient IMR-32cells were significantly lower (28%, p < 0.01)than in controls. and Zn deficient + DA, respectively ).In control cells incubated with DA, the raise in GSH levels was coincident with an increase of both Gclc and Gclm mRNA and protein levels (Figure 4 B,C) . Although the percent of increase was similar in the DA-treated (Figure 4 B and C). These results indicate that a deficient neuronal Zn status can affect the capacity of cells to respond to DA-induced oxidative stress by upregulating GSH production.
Zn deficiency impairs cellular defenses against
Zn deficiency promotes GCLC cleavage in IMR-32 cells
Caspase 3 can cleave the full length GCLC to a 60 kDa peptide [35] . In IMR-32 cells incubated in Zn deficient medium for 24 h,the percentage of 60 kDA peptide relative to total GCLC content was 2.2-fold higher in the Zn deficient cells compared to controls (p < 0.001) (Fig. 5A) .Given the different intensity of both bands (Full and cleaved GCLC) we had to expose the Western blot membrane to X ray film for different periods of time, to optimize separately the sensitivity for each band. In the representative
Western blot that is shown in Fig. 5A that the 73 kDA (total GCLC) band is overexposed (saturated) in order to show clear differences in the 60 kDa peptide (cleaved GCLC).
Ratios were calculated from the optimized exposures, although corrected with samples that showed adequate intensity for the 73 and 60 kDa bands. The increase in GCLC cleavage was prevented when cells were incubated in Zn deficient media and in the presence of the caspase-3 inhibitor Ac-VEID-CHO (50 µM) (Fig. 5A ).The content of 60 kDa fragment was markedly higher in Zn deficient cells incubated with than without DA ( Figure 5A ).The observed increase in GCLC cleavage was paralleled by a similar pattern of increase in the cleavage of PARP, a major caspase-3 substrate involved in apoptosis (Fig. 5B, right panel) , measured as the ratio of the cleaved (85 kDa) peptide versus the full length protein (116 kDa).The activity of caspase-3 in the Zn deficient cells incubated with DA was significantly higher than in all other groups after 6 h incubation, and remained high up to 24 h (Fig. 5B) . After 24 h, caspase-3 activity was 2.9-and 3.7-fold higher in cells incubated in Zn deficient medium without and with DA, respectively, compared to cells incubated in control medium. Results show that Zn deficiency leads to a caspase 3-mediated cleavage of GCLC.
Discussion
Oxidative stress, altered thiol redox status, disregulation of redox signaling, and 1  2  3  4  5  6  7  8  9  10  11  12  13  14  15  16  17  18  19  20  21  22  23  24  25  26  27  28  29  30  31  32  33  34  35  36  37  38  39  40  41  42  43  44  45  46  47  48  49  50  51  52  53  54  55  56  57  58  59  60 In terms of GSH synthesis, we observed that Zn deficiency impaired the brain/neuronal cell capacity to upregulate components of the GSH synthetic pathway as a protective response to oxidative stress. In ZD neuronal cells and fetal brain, low GSH levels were coincident with a decreased expression (protein and mRNA levels) of the catalytic and modulatory GCL subunits. The activation of transcription factor (Nrf2), that regulates GCL subunit expression, was also impaired under Zn deficiency conditions. These results suggest that the GSH depletion occurring as a consequence of neuronal Zn deficiency can in part occur through an impaired transcriptional GCL regulation. In conditions of oxidative stress, in this case induced by DA, the capacity of GSH reductase to reduce GSSG can be exceeded. Astrocytes and neurons have an ATPdependent multi drug resistance-associated protein-1 transporter which actively mediates GSSG efflux to prevent a toxic GSSG accumulation inside the cell (Hirrlinger et al. 2002; Minich et al. 2006) . GSSG efflux and an impaired capacity to synthesize GSH could explain the low levels of total GSH observed in the zinc deficient cells exposed to DA.
Results suggest that, as previously observed for lead and iron toxicity(Aimo and 1  2  3  4  5  6  7  8  9  10  11  12  13  14  15  16  17  18  19  20  21  22  23  24  25  26  27  28  29  30  31  32  33  34  35  36  37  38  39  40  41  42  43  44  45  46  47  48  49  50  51  52  53  54  55  56  57  58  59  60 in association with altered Nrf-2 signaling and decreased GSH levels (Cortese et al.
2008).
It has been previously reported that GCLC is a substrate of caspase-3-mediated cleavage during apoptotic cell death ( 1  2  3  4  5  6  7  8  9  10  11  12  13  14  15  16  17  18  19  20  21  22  23  24  25  26  27  28  29  30  31  32  33  34  35  36  37  38  39  40  41  42  43  44  45  46  47  48  49  50  51  52  53  54  55  56  57  58  59 In summary, this work shows that a decreased Zn availability impairs the GSH synthetic pathway in neuronal cells and fetal brain leading to low GSH brain/neuronal content. Importantly, it demonstrates that this decrease in part occurs as a result of both transcriptional (Nrf2 activation) and post-translational (caspase 3-mediated cleavage)
effects on GCL, a central enzyme in GSH synthesis. Findings stress the concept that an impaired capacity to regulate GSH metabolism under conditions of restricted Zn supply could turn neurons more susceptible to pro-oxidant insults like DA. 1  2  3  4  5  6  7  8  9  10  11  12  13  14  15  16  17  18  19  20  21  22  23  24  25  26  27  28  29  30  31  32  33  34  35  36  37  38  39  40  41  42  43  44  45  46  47  48  49  50  51  52  53  54  55  56  57  58 After quantification, results were expressed as the ratio GCLC or GCLM/β-tubulin. B-GCLC and GCLM mRNA levels were measured by RT-PCR and values normalized to those of the ribosomal protein L32 (RiboL32). C-GCL activity was measured in IMR-32 1  2  3  4  5  6  7  8  9  10  11  12  13  14  15  16  17  18  19  20  21  22  23  24  25  26  27  28  29  30  31  32  33  34  35  36  37  38  39  40  41  42  43  44  45  46  47  48  49  50  51  52  53  54  55  56  57  58  59  60 1  2  3  4  5  6  7  8  9  10  11  12  13  14  15  16  17  18  19  20  21  22  23  24  25  26  27  28  29  30  31  32  33  34  35  36  37  38  39  40  41  42  43  44  45  46  47  48  49  50  51  52  53  54  55  56  57  58  59 1  2  3  4  5  6  7  8  9  10  11  12  13  14  15  16  17  18  19  20  21  22  23  24  25  26  27  28  29  30  31  32  33  34  35  36  37  38  39  40  41  42  43  44  45  46  47  48  49  50  51  52  53  54  55  56  57  58  59  60 Figure 1: Zn deficiency decreased GSH content and GCL expression in rat fetal brain. Rat dams were fed control (C) or marginal zinc (MZD) diets from gestation day 0 until GD19. Fetal brains were excised and processed for the different determinations as described in the Materials and Methods section. A-GSH concentration in 100,000 x g supernatants from MZ and control GD19 fetal brain were determined by HPLC. B-Fetal brain GCLC, GCLM and β-tubulin content was measured in total homogenates by Western blot. One representative image is shown. After quantification, results were expressed as the ratio GCLC or GCLM/β-tubulin. C-GCLC and GCLM mRNA levels were measured by RT-PCR and values normalized to those of the ribosomal protein L32 (RPL32 1  2  3  4  5  6  7  8  9  10  11  12  13  14  15  16  17  18  19  20  21  22  23  24  25  26  27  28  29  30  31  32  33  34  35  36  37  38  39  40  41  42  43  44  45  46  47  48  49  50  51  52  53  54  55  56  57  58 59 60 1  2  3  4  5  6  7  8  9  10  11  12  13  14  15  16  17  18  19  20  21  22  23  24  25  26  27  28  29  30  31  32  33  34  35  36  37  38  39  40  41  42  43  44  45  46  47  48  49  50  51  52  53  54  55  56  57  58 59 60 1  2  3  4  5  6  7  8  9  10  11  12  13  14  15  16  17  18  19  20  21  22  23  24  25  26  27  28  29  30  31  32  33  34  35  36  37  38  39  40  41  42  43  44  45  46  47  48  49  50  51  52  53  54  55  56  57  58 59 60 1  2  3  4  5  6  7  8  9  10  11  12  13  14  15  16  17  18  19  20  21  22  23  24  25  26  27  28  29  30  31  32  33  34  35  36  37  38  39  40  41  42  43  44  45  46  47  48  49  50  51  52  53  54  55  56  57  58  59  60 
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